BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 29153715)

  • 21. TPGS functionalized mesoporous silica nanoparticles for anticancer drug delivery to overcome multidrug resistance.
    Zhao P; Li L; Zhou S; Qiu L; Qian Z; Liu X; Cao X; Zhang H
    Mater Sci Eng C Mater Biol Appl; 2018 Mar; 84():108-117. PubMed ID: 29519418
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Breast cancer targeted chemotherapy based on doxorubicin-loaded bombesin peptide modified nanocarriers.
    Wang C; Sun X; Wang K; Wang Y; Yang F; Wang H
    Drug Deliv; 2016 Oct; 23(8):2697-2702. PubMed ID: 26203692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hollow mesoporous organosilica nanoparticles: a generic intelligent framework-hybridization approach for biomedicine.
    Chen Y; Meng Q; Wu M; Wang S; Xu P; Chen H; Li Y; Zhang L; Wang L; Shi J
    J Am Chem Soc; 2014 Nov; 136(46):16326-34. PubMed ID: 25343459
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Facile preparation of near-infrared fluorescence and magnetic resonance dual-modality imaging probes based on mesoporous organosilica nanoparticles.
    Li Y; Guo W; Su X; Lu N; Wu G; Ou-Yang L; Dang M; Tao J; Teng Z
    J Colloid Interface Sci; 2019 Mar; 539():277-286. PubMed ID: 30590235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Construction and Biological Evaluation of Multiple Modification Hollow Mesoporous Silicone Doxorubicin Nanodrug Delivery System.
    Hu M; Zhang W; Chen W; Chen Y; Huang Q; Bao Q; Lin T; Wang L; Zhang S
    AAPS PharmSciTech; 2022 Jun; 23(6):180. PubMed ID: 35761120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cisplatin-Stitched Polysaccharide Vesicles for Synergistic Cancer Therapy of Triple Antagonistic Drugs.
    Deshpande NU; Jayakannan M
    Biomacromolecules; 2017 Jan; 18(1):113-126. PubMed ID: 28064505
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mesoporous organosilica nanoparticles with large radial pores via an assembly-reconstruction process in bi-phase.
    Dang M; Li W; Zheng Y; Su X; Ma X; Zhang Y; Ni Q; Tao J; Zhang J; Lu G; Teng Z; Wang L
    J Mater Chem B; 2017 Apr; 5(14):2625-2634. PubMed ID: 32264041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A co-delivery system based on paclitaxel grafted mPEG-b-PLG loaded with doxorubicin: preparation, in vitro and in vivo evaluation.
    Li Q; Lv S; Tang Z; Liu M; Zhang D; Yang Y; Chen X
    Int J Pharm; 2014 Aug; 471(1-2):412-20. PubMed ID: 24905776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Folate/N-acetyl glucosamine conjugated mesoporous silica nanoparticles for targeting breast cancer cells: A comparative study.
    Kumar P; Tambe P; Paknikar KM; Gajbhiye V
    Colloids Surf B Biointerfaces; 2017 Aug; 156():203-212. PubMed ID: 28531877
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis of sandwich-like molybdenum sulfide/mesoporous organosilica nanosheets for photo-thermal conversion and stimuli-responsive drug release.
    Su X; Wang J; Zhang J; Yuwen L; Zhang Q; Dang M; Tao J; Ma X; Wang S; Teng Z
    J Colloid Interface Sci; 2017 Jun; 496():261-266. PubMed ID: 28235720
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Facile Synthesis of Monodisperse Hollow Mesoporous Organosilica/Silica Nanospheres by an in Situ Dissolution and Reassembly Approach.
    Su X; Tang Y; Li Y; Wang Z; Tao J; Chen K; Liu Y; Wu J; Wang D; Teng Z
    ACS Appl Mater Interfaces; 2019 Mar; 11(12):12063-12069. PubMed ID: 30789253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Redox-responsive nanoparticles from the single disulfide bond-bridged block copolymer as drug carriers for overcoming multidrug resistance in cancer cells.
    Wang YC; Wang F; Sun TM; Wang J
    Bioconjug Chem; 2011 Oct; 22(10):1939-45. PubMed ID: 21866903
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enzyme and Thermal Dual Responsive Amphiphilic Polymer Core-Shell Nanoparticle for Doxorubicin Delivery to Cancer Cells.
    Kashyap S; Singh N; Surnar B; Jayakannan M
    Biomacromolecules; 2016 Jan; 17(1):384-98. PubMed ID: 26652038
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biodegradable Periodic Mesoporous Organosilica (BPMO) Loaded with Daunorubicin: A Promising Nanoparticle-Based Anticancer Drug.
    Mai NXD; Birault A; Matsumoto K; Ta HKT; Intasa-Ard SG; Morrison K; Thang PB; Doan TLH; Tamanoi F
    ChemMedChem; 2020 Apr; 15(7):593-599. PubMed ID: 32020745
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Self-assembled highly ordered ethane-bridged periodic mesoporous organosilica and its application in HPLC.
    Huang L; Lu J; Di B; Feng F; Su M; Yan F
    J Sep Sci; 2011 Sep; 34(18):2523-7. PubMed ID: 21793206
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Co-delivery of doxorubicin and pH-sensitive curcumin prodrug by transferrin-targeted nanoparticles for breast cancer treatment.
    Cui T; Zhang S; Sun H
    Oncol Rep; 2017 Feb; 37(2):1253-1260. PubMed ID: 28075466
    [TBL] [Abstract][Full Text] [Related]  

  • 37. pH and redox dual-sensitive polysaccharide nanoparticles for the efficient delivery of doxorubicin.
    Yang S; Tang Z; Zhang D; Deng M; Chen X
    Biomater Sci; 2017 Sep; 5(10):2169-2178. PubMed ID: 28914292
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Soft mesoporous organosilica nanorods with gold plasmonic core for significantly enhanced cellular uptake.
    Chen K; Tao J; Shi W; Su X; Cao X; Peng X; Bao L; Feng Z; Zhao Y; Mai X; Wang L; Lu G; Teng Z
    J Colloid Interface Sci; 2019 Aug; 550():81-89. PubMed ID: 31055140
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of biotinylated-EGF-modified gelatin nanoparticle carrier to enhance cisplatin accumulation in cancerous lungs via inhalation.
    Tseng CL; Su WY; Yen KC; Yang KC; Lin FH
    Biomaterials; 2009 Jul; 30(20):3476-85. PubMed ID: 19345990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Doxorubicin loaded large-pore mesoporous hydroxyapatite coated superparamagnetic Fe3O4 nanoparticles for cancer treatment.
    Abbasi Aval N; Pirayesh Islamian J; Hatamian M; Arabfirouzjaei M; Javadpour J; Rashidi MR
    Int J Pharm; 2016 Jul; 509(1-2):159-167. PubMed ID: 27234695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.